237 related articles for article (PubMed ID: 15363661)
1. Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation.
Ryu SD; Yi HG; Cha YN; Kang JH; Kang JS; Jeon YC; Park HK; Yu TM; Lee JN; Park CS
Life Sci; 2004 Oct; 75(21):2559-72. PubMed ID: 15363661
[TBL] [Abstract][Full Text] [Related]
2. Methionine S-oxidation in human and rabbit liver microsomes: evidence for a high-affinity methionine S-oxidase activity that is distinct from flavin-containing monooxygenase 3.
Ripp SL; Itagaki K; Philpot RM; Elfarra AA
Arch Biochem Biophys; 1999 Jul; 367(2):322-32. PubMed ID: 10395751
[TBL] [Abstract][Full Text] [Related]
3. Roles of FMO and CYP450 in the metabolism in human liver microsomes of S-methyl-N,N-diethyldithiocarbamate, a disulfiram metabolite.
Pike MG; Martin YN; Mays DC; Benson LM; Naylor S; Lipsky JJ
Alcohol Clin Exp Res; 1999 Jul; 23(7):1173-9. PubMed ID: 10443982
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, sequencing, and expression in Escherichia coli of mouse flavin-containing monooxygenase 3 (FMO3): comparison with the human isoform.
Falls JG; Cherrington NJ; Clements KM; Philpot RM; Levi PE; Rose RL; Hodgson E
Arch Biochem Biophys; 1997 Nov; 347(1):9-18. PubMed ID: 9344459
[TBL] [Abstract][Full Text] [Related]
5. Suppression of flavin-containing monooxygenase by overproduced nitric oxide in rat liver.
Park CS; Baek HM; Chung WG; Lee KH; Ryu SD; Cha YN
Mol Pharmacol; 1999 Sep; 56(3):507-14. PubMed ID: 10462538
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450.
Chung WG; Park CS; Roh HK; Lee WK; Cha YN
Jpn J Pharmacol; 2000 Oct; 84(2):213-20. PubMed ID: 11128045
[TBL] [Abstract][Full Text] [Related]
7. Flavin-containing monooxygenase 1-catalysed N,N-dimethylamphetamine N-oxidation.
Lee SK; Kang MJ; Jin C; In MK; Kim DH; Yoo HH
Xenobiotica; 2009 Sep; 39(9):680-6. PubMed ID: 19552509
[TBL] [Abstract][Full Text] [Related]
8. Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes.
Ripp SL; Itagaki K; Philpot RM; Elfarra AA
Drug Metab Dispos; 1999 Jan; 27(1):46-52. PubMed ID: 9884308
[TBL] [Abstract][Full Text] [Related]
9. Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity.
Can Demirdöğen B; Adali O
Cell Biochem Funct; 2005; 23(4):245-51. PubMed ID: 15473006
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine.
Ripp SL; Overby LH; Philpot RM; Elfarra AA
Mol Pharmacol; 1997 Mar; 51(3):507-15. PubMed ID: 9058607
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Flavin-Containing Monooxygenase 3 Enzyme Suppressed by Type 1 Allergy-Produced Nitric Oxide.
Tanino T; Bando T; Komada A; Nojiri Y; Okada Y; Ueda Y; Sakurai E
Drug Metab Dispos; 2017 Nov; 45(11):1189-1196. PubMed ID: 28760731
[TBL] [Abstract][Full Text] [Related]
12. Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity.
Krause RJ; Lash LH; Elfarra AA
J Pharmacol Exp Ther; 2003 Jan; 304(1):185-91. PubMed ID: 12490590
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: immunochemical and kinetic evidence for FMO3 being the major catalyst.
Krause RJ; Ripp SL; Sausen PJ; Overby LH; Philpot RM; Elfarra AA
Arch Biochem Biophys; 1996 Sep; 333(1):109-16. PubMed ID: 8806760
[TBL] [Abstract][Full Text] [Related]
14. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers.
Vuppugalla R; Mehvar R
Drug Metab Dispos; 2004 Dec; 32(12):1446-54. PubMed ID: 15383494
[TBL] [Abstract][Full Text] [Related]
15. Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomeline.
Ring BJ; Wrighton SA; Aldridge SL; Hansen K; Haehner B; Shipley LA
Drug Metab Dispos; 1999 Oct; 27(10):1099-103. PubMed ID: 10497134
[TBL] [Abstract][Full Text] [Related]
16. Flavin-containing monooxygenase activity in human liver microsomes.
McManus ME; Stupans I; Burgess W; Koenig JA; Hall PM; Birkett DJ
Drug Metab Dispos; 1987; 15(2):256-61. PubMed ID: 2882987
[TBL] [Abstract][Full Text] [Related]
17. Hepatic flavin-containing monooxygenase activity attenuated by cGMP-independent nitric oxide-mediated mRNA destabilization.
Ryu SD; Kang JH; Yi HG; Nahm CH; Park CS
Biochem Biophys Res Commun; 2004 Nov; 324(1):409-16. PubMed ID: 15465034
[TBL] [Abstract][Full Text] [Related]
18. Benzydamine as a useful substrate of hepatic flavin-containing monooxygenase activity in veterinary species.
Capolongo F; Santi A; Anfossi P; Montesissa C
J Vet Pharmacol Ther; 2010 Aug; 33(4):341-6. PubMed ID: 20646194
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.
Parte P; Kupfer D
Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
Mani C; Hodgson E; Kupfer D
Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
